Source: Eur Respir J 2003; 22: 865



Rating:

Share or cite this content

Citations should be made in the following way:
Ernst P., Suissa S.. N-acetylcysteine is unlikely to reduce hospitalisation for chronic obstructive pulmonary disease. Eur Respir J 2003; 22: 865

Member's Comments

No comment yet.

Related content which might interest you: N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease Source: Eur Respir J 2003; 21: 795-798 Year: 2003 Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients Source: Eur Respir J 2003; 21: 58-67 Year: 2003 Acute coronary events during acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2007 - Clinical aspects in COPD Year: 2007 Pulmonary rehabilitation and its effect on exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease Source: Annual Congress 2005 - Pulmonary rehabilitation: an evidence-based intervention Year: 2005 Oral nutritional supplementation during hospitalization for an acute exacerbation of chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 593s Year: 2002 The risk of repeated hospitalizations for exacerbations of chronic obstructive pulmonary disease Source: International Congress 2018 – Primary care management of COPD Year: 2018 Predictors of mortality after hospitalisation for acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2011 - COPD exacerbation Year: 2011 Proactive integrated care improves quality of life in patients with COPD Source: Eur Respir J 2009; 33: 1031-1038 Year: 2009 The effects of national lockdown on incidence of acute exacerbation of chronic obstructive pulmonary disease Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases Year: 2021 Hospitalization burden in chronic obstructive pulmonary disease patients after pulmonary rehabilitation Source: Annual Congress 2003 - Outcome of integrated care on burden of chronic respiratory failure Year: 2003 Is increased gastro-intestinal permeability related to exacerbation in patients with chronic obstructive pulmonary disease? Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 The effect of early pulmonary rehabilitation on the treatment of ICU chronic obstructive pulmonary disease with severe respiratory failure Source: International Congress 2018 – Muscles and diaphragm, and quality improvement Year: 2018 Readmissions after hospitalization for acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD exacerbation Year: 2010 Effect of systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 624s Year: 2006 The impact of using different symptom-based exacerbation algorithms in patients with COPD Source: Eur Respir J 2011; 37: 1260-1268 Year: 2011 Determinants of discharge treatment after hospitalization for an acute exacerbation of COPD Source: Annual Congress 2007 - Treatment and care of COPD Year: 2007 Antibiotics in acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009 Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: what studies are still needed? Source: Eur Respir J 2002; 19: 966-975 Year: 2002 Prolonging the interval to the next acute exacerbations Source: Annual Congress 2005 - Infection and acute exacerbation of COPD: what do we know? Year: 2005